Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
KYORIN Pharma, Apr-Jun (1Q) Ordinary Profit Increases by 85%, Exceeds First Half Plan
4569 KYORIN Pharmaceutical Co.,Ltd. 【J-GAAP】
Earnings ReportKYORIN Pharmaceutical Co.,Ltd. <4569> [TSE Prime] announced its financial results after the market closed on July 31st (15:30). The consolidated ordinary profit for the first quarter of the fiscal year ending March 2026 (April to June) expanded 2.62 billion yen, an increase 85.2% compared to the same period last year. Progress toward the plan for the six months ending September (first half) of 1.80 billion yen is 145.8%, already exceeding the target and also exceeding the five-year average of 82.2%.
In the most recent three-month period, from April to June (1Q), the operating profit margin significantly improved from 4.0% in the same period last year to 7.8%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Apr - Jun, 2023 | 27,854 | 871 | 1,074 | 787 | 13.8 | 68.1 | Aug 2, 2023 | J-GAAP |
| Apr - Jun, 2024 | 28,419 | 1,150 | 1,417 | 885 | 15.4 | 69.1 | Jul 31, 2024 | J-GAAP |
| Apr - Jun, 2025 | 30,229 | 2,368 | 2,624 | 2,100 | 36.6 | 145.8 | Jul 31, 2025 | J-GAAP |
| YoY | +6.4% | +105.9% | +85.2% | +137.3% | +137.2% |
Current Period Guidance
H1 Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Apr - Sep, 2024 | 55,139 | 1,549 | 2,050 | 1,255 | 21.9 | 20 | Nov 7, 2024 | J-GAAP |
| Apr - Sep, 2025 Guidance | 57,400 | 1,700 | 1,800 | 1,400 | 24.4 | 20 | May 12, 2025 | J-GAAP |
| YoY | +4.1% | +9.7% | -12.2% | +11.6% | +11.5% |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2024 | 119,532 | 6,234 | 6,822 | 5,475 | 95.4 | 52 | May 10, 2024 | J-GAAP |
| Mar, 2025 | 130,087 | 12,567 | 13,219 | 9,086 | 158.2 | 57 | May 12, 2025 | J-GAAP |
| Mar, 2026 Guidance | 127,000 | 6,100 | 6,300 | 4,800 | 83.6 | 57 | May 12, 2025 | J-GAAP |
| YoY | -2.4% | -51.5% | -52.3% | -47.2% | -47.2% |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Apr - Jun, 2024 | 28,419 | 1,150 | 1,417 | 885 | 15.4 | 4.0 | Jul 31, 2024 | J-GAAP |
| Jul - Sep, 2024 | 26,720 | 399 | 633 | 370 | 6.4 | 1.5 | Nov 7, 2024 | J-GAAP |
| Oct - Dec, 2024 | 34,147 | 1,566 | 1,703 | 1,184 | 20.6 | 4.6 | Feb 5, 2025 | J-GAAP |
| Jan - Mar, 2025 | 40,801 | 9,452 | 9,466 | 6,647 | 115.7 | 23.2 | May 12, 2025 | J-GAAP |
| Apr - Jun, 2025 | 30,229 | 2,368 | 2,624 | 2,100 | 36.6 | 7.8 | Jul 31, 2025 | J-GAAP |
| YoY | +6.4% | +105.9% | +85.2% | +137.3% | +137.2% |
Related Articles
NISSHIN SEIFUN, Apr-Jun (1Q) Ordinary Profit Decreases by 11%
Togami Electric Mfg, Apr-Jun (1Q) Ordinary Profit Decreases by 26%
TOKYOTOKEIBA, First Half Ordinary Profit Unexpectedly Revised Upward by 8%
Fenwal Controls of Japan, Ordinary Profit Forecast for the Fiscal Year Revised Upward by 58%
Electric Power Development, Apr-Jun (1Q) Ordinary Profit Increases by 2.1 times
KONICA MINOLTA, Apr-Jun (1Q) Net Income Turns to Profit
Vega, Apr-Jun (1Q) Ordinary Profit Increases by 32%
Keihanshin Building, Apr-Jun (1Q) Ordinary Profit Increases by 1%
Mizuho Financial, Net Income Forecast for the Fiscal Year Revised Upward by 9%, Raises Record High Profit Forecast
TORII PHARMA, First Half Ordinary Profit Increases by 16%